346 related articles for article (PubMed ID: 10099899)
1. Enhancement of ocular drug penetration.
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Crit Rev Ther Drug Carrier Syst; 1999; 16(1):85-146. PubMed ID: 10099899
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
3. [Biological availability of ophthalmic drugs. 1. Increasing drug permeability in the cornea].
Masteiková R; Chalupová Z; Savickiene N
Ceska Slov Farm; 2004 Mar; 53(2):73-9. PubMed ID: 15095575
[TBL] [Abstract][Full Text] [Related]
4. Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies.
Velpandian T
Expert Opin Drug Deliv; 2009 Mar; 6(3):255-70. PubMed ID: 19327043
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.
Souto EB; Doktorovova S; Gonzalez-Mira E; Egea MA; Garcia ML
Curr Eye Res; 2010 Jul; 35(7):537-52. PubMed ID: 20597640
[TBL] [Abstract][Full Text] [Related]
6. Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
Ahmed I; Patton TF
Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):584-7. PubMed ID: 3884542
[TBL] [Abstract][Full Text] [Related]
7. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
Jiao J
Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
[TBL] [Abstract][Full Text] [Related]
8. Molecular design for enhancement of ocular penetration.
Shirasaki Y
J Pharm Sci; 2008 Jul; 97(7):2462-96. PubMed ID: 17918725
[TBL] [Abstract][Full Text] [Related]
9. [Bioavailability of drugs applied to the eye externally].
Sieradzki E
Klin Oczna; 1991 Jan; 93(1):34-6. PubMed ID: 2046287
[TBL] [Abstract][Full Text] [Related]
10. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
[TBL] [Abstract][Full Text] [Related]
11. [Modulation of drug penetration in the skin].
Kalbitz J; Neubert R; Wohlrab W
Pharmazie; 1996 Sep; 51(9):619-37. PubMed ID: 9011873
[TBL] [Abstract][Full Text] [Related]
12. Advances in ocular drug delivery.
Rawas-Qalaji M; Williams CA
Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.
Attar M; Shen J; Ling KH; Tang-Liu D
Expert Opin Drug Deliv; 2005 Sep; 2(5):891-908. PubMed ID: 16296785
[TBL] [Abstract][Full Text] [Related]
14. [Transcorneal drug delivery: prospects for the use of liposomes].
Aliautdin RN; Iezhitsa IN; Agarval R
Vestn Oftalmol; 2014; 130(4):117-22. PubMed ID: 25306734
[TBL] [Abstract][Full Text] [Related]
15. Ocular preparations: the formulation approach.
Kaur IP; Kanwar M
Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
[TBL] [Abstract][Full Text] [Related]
16. Ocular penetration of topical Delta9-tetrahydrocannabinol from rabbit corneal or cul-de-sac application site.
Green KE; Kearse CE
Curr Eye Res; 2000 Jul; 21(1):566-70. PubMed ID: 11035538
[TBL] [Abstract][Full Text] [Related]
17. Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin.
Di Colo G; Zambito Y; Burgalassi S; Nardini I; Saettone MF
Int J Pharm; 2004 Apr; 273(1-2):37-44. PubMed ID: 15010128
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of the eye. Proctor lecture.
Mishima S
Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):504-41. PubMed ID: 6116682
[TBL] [Abstract][Full Text] [Related]
19. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
Loftsson T; Sigurdsson HH; Konrádsdóttir F; Gísladóttir S; Jansook P; Stefánsson E
Pharmazie; 2008 Mar; 63(3):171-9. PubMed ID: 18444504
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
